Cleveland Clinic researchers are leading three clinical trials investigating injectable biologic therapies for hip and knee osteoarthritis, including birth tissue particulate, bone marrow aspirate concentrate and platelet-rich plasma. These regenerative therapies one day may offer alternatives to joint replacement.